President Trump took aim at New York Times journalist Maggie Haberman on Saturday, posting a lengthy broadside on Truth Social that accused her of a decade of inaccurate coverage and warned she would face consequences through his pending multibillion-dollar lawsuit against the paper.
The post came after Haberman questioned the president's cognitive health and physical fitness during an appearance on MS Now, where she described the administration's approach to medical disclosures as opaque. Trump responded by touting a recent physical at Walter Reed National Military Medical Center and claiming he had voluntarily taken, and passed, cognitive tests three times.
The Hill reported the exchange Saturday afternoon, capturing both Trump's Truth Social post and the response from Haberman's colleague Jonathan Swan on X.
Trump's post used a mocking nickname for Haberman and directly tied his criticism to the pending lawsuit against the Times. From the post:
"Maggot Hagerman has covered me incorrectly for ten years. She has made a living off her bad reporting, and will pay the price when our Multi Billion Dollar Lawsuit against The Failing New York Times gets to Court."
He went on to defend his fitness in blunt terms, framing his willingness to undergo cognitive testing as a mark of transparency that sets him apart from other officeholders:
"I just finished a perfect physical at Walter Reed, I do it every six months, and I requested another Cognitive Test, the only President to do so, three times, and I aced them all. Few people in Washington, D.C., could do so, including Maggot and her flunky associate, Jonathan Swan."
Trump did not specify the date of his most recent Walter Reed visit, the type of cognitive test administered, or who conducted it. No official medical documentation accompanied the claims.
Haberman's comments on MS Now centered on what she characterized as a lack of transparency from the White House about the president's health. She told the program:
"His health is like a black box inside that administration. They have released less and less information."
The Hill noted that Haberman's remarks followed what it described as "several high-profile blunders and verbal mishaps" by Trump. Among those cited: an instance in which Trump referred to Iran as "the Islamic State of Japan," and a moment at the NATO Summit in Ankara, Turkey, where he mistakenly called Ukrainian President Volodymyr Zelensky by Russian President Vladimir Putin's name. No specific dates were provided for either incident.
Verbal slips by presidents are nothing new, of course. Every modern occupant of the Oval Office has mangled a name or fumbled a phrase on camera. Whether those moments amount to evidence of decline, or simply the ordinary wear of a grueling schedule, depends largely on who is doing the interpreting and what they want the audience to conclude.
Jonathan Swan, who co-authored the book "Regime Change" with Haberman, posted twice on X after Trump's broadside. His first reply was brief and direct:
"I would be honored to do another on-camera interview with President Trump whenever he wants."
In a second post, Swan struck a lighter tone, writing: "Many people disagree with the president's assessment. Thanks to you all for reading." He accompanied that post with a screenshot of Amazon's "Top 20 Most Sold & Most Read Books of the Week," which showed "Regime Change" sitting at number one for the week of July 5, 2026.
The implication was hard to miss. Presidential attention, even hostile attention, tends to move product. Whether Swan's response was a genuine olive branch or a savvy bit of self-promotion, the book's sales ranking suggests the exchange did Haberman and Swan no commercial harm.
Trump's reference to a "Multi Billion Dollar Lawsuit" against the Times is consistent with a pattern of aggressive legal action he has pursued against major media outlets. The case name, court, filing date, and specific claims in the Times suit remain unclear from the available reporting. It is also unknown whether Haberman or Swan are named individually as defendants or whether the suit targets only the newspaper as an entity.
The president has pursued similar litigation on multiple fronts. He recently took a $475 million defamation case against CNN to the Supreme Court, signaling that he views the courts as a legitimate venue for holding outlets accountable for coverage he considers false.
That legal posture extends beyond broadcast networks. Trump's team has also pressed forward with defamation claims against print media, including a case where he hailed a favorable venue ruling in a $3.8 billion suit against the Washington Post, even as a separate element of that case fell at summary judgment.
Whether any of these suits ultimately succeed in court is an open question. But the strategy itself, using defamation law to impose real costs on outlets that publish claims the president considers false, represents a departure from the approach of prior administrations, which generally absorbed hostile coverage without reaching for litigation.
Haberman's "black box" characterization raises a fair point about presidential health disclosures, but it also invites scrutiny of who gets to define what transparency looks like. Trump says he undergoes a physical at Walter Reed every six months and has voluntarily submitted to cognitive testing three times. If those claims are accurate, that is more testing than most presidents have publicly disclosed.
The press, of course, wants documentation, test results, physician statements, detailed readouts. And there is a reasonable public interest in knowing whether a sitting president is in good health. But there is a difference between asking for more information and treating a handful of verbal slips as a medical diagnosis, which is the direction Haberman's commentary appeared to lean.
Attacks on a president's mental fitness have a long and bipartisan history. Trump himself wielded them effectively against Joe Biden. The media's willingness to raise the same questions about Trump now is not inherently unfair, but the credibility of the exercise depends on whether the same journalists applied the same standard to Biden at the same stage, or whether they spent years dismissing concerns that turned out to be well-founded.
That credibility gap is what makes Trump's counterattack resonate with his supporters, even when the language is rough. The New York Times spent considerable effort downplaying Biden's visible decline before reversing course only when it became undeniable. Haberman herself covered that story. The question of whether she and her colleagues are now applying a consistent standard, or simply deploying a familiar weapon against a Republican president, is one her readers are entitled to ask.
Trump has not been shy about pushing back against media figures who target his family and inner circle, and this latest exchange fits a well-established pattern.
Several key facts remain unresolved. The specific cognitive test Trump references, its type, administrator, and precise dates, has not been publicly documented. The details of the pending lawsuit against the Times, including its legal basis and current status, are not laid out in available reporting. And the White House has not, as of the article's publication, issued a formal response to Haberman's MS Now appearance beyond Trump's own post.
The president has also shown a willingness to use the legal system against individual adversaries, not just institutions. His legal team recently moved to merge the E. Jean Carroll cases in a maneuver that could reshape both judgments, another example of the aggressive posture that defines this White House's relationship with its critics.
Swan's offer to sit for another on-camera interview is worth noting. If the president's health is truly the concern, a long-form, unedited conversation would do more to settle the question than cable news speculation or social media exchanges. Whether either side takes the other up on that remains to be seen.
When the press spends years ignoring one president's decline and then races to diagnose another's, the public stops trusting the diagnosis, and starts wondering about the doctor.